Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
jollab
- Development stage
- Unknown
- Lead developer
- Shahid Beheshti University of Medical Sciences
- Administration
- Oral
01
Overview
Jollab is a traditional Persian (Iranian) medicine formulation prepared as a syrup containing rose water (*Rosa damascena*), saffron (*Crocus sativus*), and candy sugar. It is primarily investigated for the treatment of functional dyspepsia (FD) and its associated gastrointestinal and depressive symptoms. The therapeutic effects are attributed to the synergistic properties of its herbal components, particularly saffron, which is known for its antidepressant and psychoactive effects. Clinical studies conducted by Shahid Beheshti University of Medical Sciences have demonstrated its safety and efficacy in improving dyspeptic symptoms compared to placebo.
- Other names
- Jollab syrupGolab-Saffron syrup
Beyond the preview
Go deeper on jollab.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on jollab.